Miller Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
Miller Investment Management's PPH Position: Q2 2026 in Review
Miller Investment Management reduced its VanEck Pharmaceutical ETF (PPH) stake by 25% in Q2 2026, selling an estimated $3.49M and leaving 100,256 shares worth $11M. The position accounts for 1% of the portfolio, ranked #20.
Miller Investment Management first reported a position in PPH in Q4 2022 and has held it in 15 quarters since. The position peaked at $19.7M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- Miller Investment Management held 100,256 shares of VanEck Pharmaceutical ETF worth $11M as of Q2 2026.
- Miller Investment Management sold 33,682 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $3.49M.
- VanEck Pharmaceutical ETF made up 1% of Miller Investment Management's portfolio in Q2 2026, its #20 holding.
- Miller Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2022 and has held it in 15 quarters since.
- Miller Investment Management's VanEck Pharmaceutical ETF position peaked at $19.7M in Q3 2024.
- 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on Miller Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.